These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27856480)

  • 1. Dysarthria in individuals with Parkinson's disease: a protocol for a binational, cross-sectional, case-controlled study in French and European Portuguese (FraLusoPark).
    Pinto S; Cardoso R; Sadat J; Guimarães I; Mercier C; Santos H; Atkinson-Clement C; Carvalho J; Welby P; Oliveira P; D'Imperio M; Frota S; Letanneux A; Vigario M; Cruz M; Martins IP; Viallet F; Ferreira JJ
    BMJ Open; 2016 Nov; 6(11):e012885. PubMed ID: 27856480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acoustic evaluation of short-term effects of repetitive transcranial magnetic stimulation on motor aspects of speech in Parkinson's disease.
    Eliasova I; Mekyska J; Kostalova M; Marecek R; Smekal Z; Rektorova I
    J Neural Transm (Vienna); 2013 Apr; 120(4):597-605. PubMed ID: 23254927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of dysprosody in Parkinson's disease over time--a longitudinal study.
    Skodda S; Rinsche H; Schlegel U
    Mov Disord; 2009 Apr; 24(5):716-22. PubMed ID: 19117364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frenchay dysarthria assessment (FDA-2) in Parkinson's disease: cross-cultural adaptation and psychometric properties of the European Portuguese version.
    Cardoso R; Guimarães I; Santos H; Loureiro R; Domingos J; de Abreu D; Gonçalves N; Pinto S; Ferreira J
    J Neurol; 2017 Jan; 264(1):21-31. PubMed ID: 27747392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of voice and speech symptoms in early Parkinson's disease by the Robertson dysarthria profile.
    Defazio G; Guerrieri M; Liuzzi D; Gigante AF; di Nicola V
    Neurol Sci; 2016 Mar; 37(3):443-9. PubMed ID: 26615536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial impact of Parkinson's disease-associated dysarthria: Cross-cultural adaptation and validation of the Dysarthria Impact Profile into European Portuguese.
    Cardoso R; Guimarães I; Santos H; Loureiro R; Domingos J; Abreu D; Gonçalves N; Pinto S; Ferreira JJ
    Geriatr Gerontol Int; 2018 May; 18(5):767-774. PubMed ID: 29372587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship Between Voice and Motor Disabilities of Parkinson's Disease.
    Majdinasab F; Karkheiran S; Soltani M; Moradi N; Shahidi G
    J Voice; 2016 Nov; 30(6):768.e17-768.e22. PubMed ID: 26725551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002814. PubMed ID: 11406045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct phenotypes of speech and voice disorders in Parkinson's disease after subthalamic nucleus deep brain stimulation.
    Tsuboi T; Watanabe H; Tanaka Y; Ohdake R; Yoneyama N; Hara K; Nakamura R; Watanabe H; Senda J; Atsuta N; Ito M; Hirayama M; Yamamoto M; Fujimoto Y; Kajita Y; Wakabayashi T; Sobue G
    J Neurol Neurosurg Psychiatry; 2015 Aug; 86(8):856-64. PubMed ID: 25280914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysarthria and Quality of Life in neurologically healthy elderly and patients with Parkinson's disease.
    Lirani-Silva C; Mourão LF; Gobbi LT
    Codas; 2015; 27(3):248-54. PubMed ID: 26222941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysprosody and stimulus effects in Cantonese speakers with Parkinson's disease.
    Ma JK; Whitehill T; Cheung KS
    Int J Lang Commun Disord; 2010; 45(6):645-55. PubMed ID: 19995207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dysarthria across Parkinson's disease progression. Natural history of its components: dysphonia, dysprosody and dysarthria].
    Pinto S; Ghio A; Teston B; Viallet F
    Rev Neurol (Paris); 2010 Oct; 166(10):800-10. PubMed ID: 20800250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.
    Rusz J; Tykalová T; Krupička R; Zárubová K; Novotný M; Jech R; Szabó Z; Růžička E
    J Neural Transm (Vienna); 2017 Apr; 124(4):463-470. PubMed ID: 27933492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Speech and language therapy for dysarthria in Parkinson's disease.
    Deane KH; Whurr R; Playford ED; Ben-Shlomo Y; Clarke CE
    Cochrane Database Syst Rev; 2001; (2):CD002812. PubMed ID: 11406044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Voice Use in Daily Life Studied With a Portable Voice Accumulator in Individuals With Parkinson's Disease and Matched Healthy Controls.
    Gustafsson JK; Södersten M; Ternström S; Schalling E
    J Speech Lang Hear Res; 2019 Dec; 62(12):4324-4334. PubMed ID: 31830844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease.
    Skodda S; Visser W; Schlegel U
    J Neural Transm (Vienna); 2010 Feb; 117(2):197-205. PubMed ID: 20012657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speech and Communication Changes Reported by People with Parkinson's Disease.
    Schalling E; Johansson K; Hartelius L
    Folia Phoniatr Logop; 2017; 69(3):131-141. PubMed ID: 29346787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and pattern of perceived intelligibility changes in Parkinson's disease.
    Miller N; Allcock L; Jones D; Noble E; Hildreth AJ; Burn DJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1188-90. PubMed ID: 17400592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.